000			02127 a2200553 4500
005			20250514020701.0
264		0	_c20020124
008			200201s 0 0 eng d
022			_a0887-4476
024	7		_a10.1002/syn.1113 _2doi
040			_aNLM _beng _cNLM
100	1		_aVan De Witte, Serge V
245	0	0	_aMK-801 alters the effects of priming with L-DOPA on dopamine D1 receptor-induced changes in neuropeptide mRNA levels in the rat striatal output neurons. _h[electronic resource]
260			_bSynapse (New York, N.Y.) _cJan 2002
300			_a1-11 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_a2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine _xpharmacology
650	0	4	_aAnimals
650	0	4	_aDisease Models, Animal
650	0	4	_aDizocilpine Maleate _xpharmacology
650	0	4	_aDopamine Agents _xpharmacology
650	0	4	_aDopamine Agonists _xpharmacology
650	0	4	_aDrug Interactions _xphysiology
650	0	4	_aDynorphins _xgenetics
650	0	4	_aDyskinesia, Drug-Induced _xmetabolism
650	0	4	_aEnkephalins _xgenetics
650	0	4	_aExcitatory Amino Acid Antagonists _xpharmacology
650	0	4	_aImmunohistochemistry
650	0	4	_aLevodopa _xpharmacology
650	0	4	_aMale
650	0	4	_aMotor Activity _xdrug effects
650	0	4	_aNeostriatum _xdrug effects
650	0	4	_aNeurons _xdrug effects
650	0	4	_aNeuropeptides _xgenetics
650	0	4	_aOxidopamine _xpharmacology
650	0	4	_aParkinsonian Disorders _xdrug therapy
650	0	4	_aProtein Precursors _xgenetics
650	0	4	_aRNA, Messenger _xmetabolism
650	0	4	_aRats
650	0	4	_aRats, Wistar
650	0	4	_aReceptors, Dopamine D1 _xdrug effects
650	0	4	_aReceptors, N-Methyl-D-Aspartate _xantagonists & inhibitors
650	0	4	_aTachykinins _xgenetics
650	0	4	_aTyrosine 3-Monooxygenase _xmetabolism
700	1		_aGroenewegen, Hendrik J
700	1		_aVoorn, Pieter
773	0		_tSynapse (New York, N.Y.) _gvol. 43 _gno. 1 _gp. 1-11
856	4	0	_uhttps://doi.org/10.1002/syn.1113 _zAvailable from publisher's website
999			_c11659654 _d11659654